Skip to main content
. 2021 Oct 28;8:719056. doi: 10.3389/fmolb.2021.719056

TABLE 5.

Association of promoter hypermethylation status of candidate genes with patient’s clinico-pathological features in EOC serum samples. p-value: Pearson’s chi-square and Fisher’s exact tests. Abbreviation: Pos: biomarker panel positive for methylation; Neg: biomarker panel negative for methylation; NS: not significant. A positive biomarker panel is defined as when either or both gene promoter show methylation.

SerumFeatures No. of patients HOXA9 a HIC1 a SOX1 HOXA9+HIC1 a HIC1+SOX1 SOX1+HOXA9
M U M U M U Pos Neg Pos Neg Pos Neg
Tumor 45 28 17 32 13 24 21 40 5 36 9 30 15
Healthy 25 0 25 0 25 1 24 0 25 1 24 1 24
<0.0001*** <0.0001*** < 0.0001*** <0.0001*** < 0.0001*** < 0.0001***
Histology
Serous 40 26 14 28 12 20 20 33 7 31 9 25 15
Mucinous 4 2 2 4 0 4 0 4 0 4 0 4 0
Benign 1 0 1 0 1 0 1 0 1 1 0 0 1
NS NS NS NS NS NS
FIGO stage
I/II 10 7 3 7 3 7 3 10 0 10 0 8 2
III/IV 35 21 14 25 10 17 18 28 7 26 9 21 14
NS NS NS NS NS NS
Age (Median =50)
≥ Median age 38 9 29 10 28 11 27 12 26 13 25 10 28
< Median age 32 19 13 22 10 14 18 26 6 20 12 20 12
0.0033** 0.0006*** NS <0.0001*** 0.0299* 0.0035**
Menopausal status
Pre 29 14 15 17 12 13 11 21 8 17 12 15 14
Post 41 14 27 15 26 11 10 17 24 16 25 15 26
NS NS NS 0.0149* NS NS
a

Promoter hypermethylation of DNA methylation markers-HOXA9 and HIC1 in singleplex and multiplex MethyLight assay analyzed in serum samples has been previously published (Singh et al., 2020).